Viridian Capital Advisors

How These 2 Nasdaq-Listed Marijuana Companies Found A Way To Raise $250M Without Tanking Their Stock
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
Finally, Tax Refunds! These Cannabis Companies Will Get The Most Money Back If Rescheduling Happens
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
$581M In Deals: Top States Draw Major Cannabis Investments Despite Market Downturn
Big Players In U.S. Cannabis Could Play The Stock-Value Card In M&A, New Report Shows

Viridian Capital Advisors Recent News

Cannabis Companies' Gains - U.S. Versus Canada: Averages Can Be Deceiving, Irrational Market Behavior To Blame?
Recent insights from Viridian Capital Advisors shed light on the bewildering trends in cannabis stocks. Year-to-date (YTD) data indicates that U.S. multi-state operators (MSOs) and Canadian licensed producers (LPs) have experienced drastically different fates. At a glance, U.S. MSOs show an average return of 26.4%, towering over Canadian LPs' modest 1.3%.
Beyond Amazon And Coca-Cola: Why Cannabis Is Catching Up To Blue Chip Stocks In Profitability
A recent report by Viridian Capital Advisors explores the valuation and growth prospects of cannabis stocks against those of well-established sectors like alco
What's The Net Worth Of These 4/20 Underdogs? Mid-Tier Cannabis Retailers & Cultivators Under The Spotlight
In the spotlight of Viridian Capital Advisors' latest Weekly Valuation Report are 16 Tier 2 and 3 U.S. cultivation and retail cannabis companies, each boasting market capitalizations between $10 million and $200 million.
Marijuana Investors Bet Big On Long-Term Growth Over Short-Term Earnings As Market Value Rises By 39%
Recent data from the Viridian Cannabis Deal Tracker highlights significant changes in the valuation multiples of major multi-state operators (MSOs) in the cannabis sector. The Viridian Cannabis Deal Tracker has become an indispensable tool for companies, investors and acquirers in the cannabis industry.
Cannabis Market's Trading Volume Surges Up 292%, Viridian Capital Highlights Mixed Liquidity
A recent analysis by Viridian Capital Advisors provides intriguing insights into the liquidity of cannabis companies, indicating both advancements and setbacks in the sector.
Webinar: A Look At The Cannabis Industry's $700M Potential Tax Break Amid A 70% Drop In Capital Raises
MGO and Viridian Capital Advisors have joined forces to launch the Cannabis Capital Markets report.
35 Cannabis Innovators To Watch In 2024: Leaders Shaping The Green Revolution
Discover the stories and future prospects of 35 influential figures in the cannabis industry, driving innovation and shaping the evolving landscape.
Cannabis Stocks With Hidden Potential: A Closer Look At Attractively-Valued Tier-2 Firms
In a comprehensive report by Viridian Capital Advisors, the spotlight is on the valuations of companies within the U.S. cultivation and retail sector, specifically those boasting market caps ranging from $100 million to $500 million —commonly referred to as ‘Tier 2’ enterprises.
Trulieve Vs The IRS Over Millions Of Dollars In Tax Refund, Relocates One Of Its Florida Stores
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) announced on Friday the filing of amended federal tax returns with refund claims for several of the company's business entities for 2019, 2020 and 2021.
Viridian Capital Advisors Led A Panel On If M&As Are On The Rise In The Cannabis Industry
Scott Greiper, founder and president of Viridian Capital Advisors, moderated a panel called “M&A: Will Rescheduling Reignite Growth?” at Benzinga’s Cannabis Capital Conference. Greiper shared some interesting statistics about the industry. According to Greiper, the amount of equity capital invested in the last year in cannabis is down 68%.
Sponsored
Pennsylvania Stands Up To Federal Law On Medical Cannabis Taxes
A large-scale tax reform measure that recently advanced through the Pennsylvania legislature includes provisions that offer a partial solution to the restrictive IRS code known as 280E, which bans tax deductions at the federal level for state-licensed medical cannabis
EXCLUSIVE: How Regulatory Reforms Could Reshape M&A Pulse In Cannabis Industry
The cannabis industry's mergers and acquisitions (M&A) landscape is undergoing a transformation, as highlighted in a recent panel discussion led by Scott Greiper, founder and president at Viridian Capital Advisors, at the Benzinga Cannabis Capital Conference in Chicago.</
Cannabis Capital: Which State Is Getting The Most Investment Money? It's Not California Or Colorado
New York has emerged as the leading state in the realm of cannabis-related capital acquisition, amassing a staggering total of $414.05 million in the last year, Viridian Capital Advisors has revealed.
Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals
In a potentially game-changing decision, the Department of Health and Human Services (HHS) recently recommended the DEA to consider reclassifying cannabis from its Sc
Cannabis Industry's Capital Crunch: Why It Needs More Funds Than Other Industries, Will Fed Legalization Change This?
Recent research conducted by Viridian Capital Advisors reveals that the cannabis sector requires more capital as compared to other similar industries.
Director Of MA Marijuana Regulator Resigns, MD Plans To Evaluate Pot's Health Effects And Recent Industry Moves
As the Benzinga Cannabis Capital Conference returns to Chicago (Sept 27-28), gathering top CEOs, investors and leaders in the marijuana industry, let's scroll through some executive moves in the space.
Cannabis Investments: Which States Are Getting The Most Capital? Here's The Top 10
The cannabis industry is witnessing a thrilling trend as Illinois stakes a claim on the top spot for the highest total invested capital over the last twelve months (LTM), concluding on June 23, 2023. Unveiled by Viridian Capital Advisors, this revelation punctuates a dynamic shift in the US investment milieu.
Cannabis Investing Got You Down? Confused? You're Not Alone, Help Is On The Way
Viridian Capital Advisors, founded and launched in 2014 by Scott Greiper is one of the earliest institutional financial and strategic advisory firms in the legal cannabis sector.
Exclusive Tool For Cannabis Investors And Entrepreneurs Goes Online After 8-Year Email Run
The constantly expanding cannabis industry compels companies to focus on “new product types and trends, form factors, and pricing to stay competitive,” wrote Forbes senior contributor Javier Hasse.
Scott Greiper Of Viridian Capital Advisors Leads Panel At Benzinga Cannabis Capital Conference
Scott Greiper, Founder and President of Viridian Capital Advisors, was a guest speaker at The Benzinga Cannabis Capital Conference in Chicago this past week. 
Sponsored
This Is The Best Investment Research Firm In Cannabis In 2022, According To Industry Experts
Viridian Capital was the winner of the Best Investment Research award at the Benzinga Cannabis Capital Conference in Chicago, Illinois.
'The World's Largest Database Of Cannabis Deals Gives Us Incredible Market Intelligence And An Edge,' Says Viridian's Scott Greiper
Lowered valuations for cannabis companies are leading to a shift in the way capital is raised and merger and acquisition activity is occurring in the cannabis space. In this context, cannabis investors can leverage their understanding of M&A to anticipate corporate strategic moves and profit.
Analyst: AYR Wellness Weakness on Guidance Overlooks Longer-Term Opportunity
On Monday, AYR Wellness (OTCQX: AYRWF) reported its financial results Monday for the three and nine months ended September 3